Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01935622 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT01935622 is a Phase 2 study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 10 participants.
The verdict
NCT01935622, a Phase 2 study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
Non-ischemic cardiomyopathy and heart failure are highly influenced by the presence of systemic inflammation. Doxycycline is a FDA-approved drug to treat bacterial infections which also shows powerful anti-inflammatory effects. In this study we plan to determine the effects of Doxycycline in patients with stable heart failure and non-ischemic cardiomyopathy on peak of aerobic exercise capacity (peak V02) and ventilator efficiency measured with a cardiopulmonary test.
Interventions
- DRUG placebo
- DRUG Doxycycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01935622
The ClinicalTrials.gov registry entry for NCT01935622 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01935622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01935622 about?
NCT01935622 is a clinical study titled "Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy". Non-ischemic cardiomyopathy and heart failure are highly influenced by the presence of systemic inflammation. Doxycycline is a FDA-approved drug to treat bacterial infections which also shows powerful anti-inflammatory effects. In this study we plan to determine the effects of Doxycycline in patie...
What is the current status of trial NCT01935622?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2012-07. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01935622?
The interventions under investigation include: placebo (DRUG), Doxycycline (DRUG).
Who is sponsoring clinical trial NCT01935622?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.